High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity

Mostrar otras versiones (1)

Breast cancer is the most common malignant tumor affecting women worldwide and is divided into the following subtypes: Luminal A, Luminal B, HER-2 overexpression and triple-negative breast cancer (TNBC). TNBC accounts for approximately 15-20% of all breast cancer cases. Due to the characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Xiong, Xifeng, Chen, Weiguang, Li, Xiaojian, Hua, Xing, Liu, Zhihe, Zhang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307591/
https://www.ncbi.nlm.nih.gov/pubmed/32626933
http://dx.doi.org/10.3892/ijo.2020.5080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307591/
https://www.ncbi.nlm.nih.gov/pubmed/32626933
http://dx.doi.org/10.3892/ijo.2020.5080

Ejemplares similares